Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients

Transplantation Proceedings

Volumn 47, Issue 3, 2015, Pages 660-665

  Yoon, S H ^a   Cho, J H ^b   Jung, H Y ^b   Choi, J Y ^b   Park, S H ^b   Kim, Y L ^b   Kim, H K ^b   Huh, S ^b   Kim, C D ^b  

^a Konyang University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; AREA UNDER THE CURVE; BK VIRUS; BK VIRUS ASSOCIATED NEPHROPATHY; BK VIRUS INFECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DRUG PULSE THERAPY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STEROID THERAPY; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD; AGED; ALLOTRANSPLANTATION; ISOLATION AND PURIFICATION; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; TUMOR VIRUS INFECTIONS;

ADULT; AGED; BK VIRUS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; VIREMIA;

EID: 84928311182     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.11.051     Document Type: Conference Paper

References (25)

1. P.J. Morris Transplantation-: a medical miracle of the 20th century N Engl J Med 23 2004 2678 2680
2. C. Alméras, F. Vetromile, V. Garrigue, I. Szwarc, V. Foulongne, and G. Mourad Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients Transpl Infect Dis 13 2011 101 108
3. H.H. Hirsch, W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, and M.J. Mihatsch Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients N Engl J Med 15 2002 488 496
4. E. Ramos, C.B. Drachenberg, J.C. Papadimitriou, O. Hamze, J.C. Fink, and D.K. Klassen Clinical course of polyoma virus nephropathy in 67 renal transplant patients J Am Soc Nephrol 13 2002 2145 2151
5. S. Schaub, H.H. Hirsch, M. Dickenmann, J. Steiger, M.J. Mihatsch, and H. Hopfer Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy Am J Transplant 10 2010 2615 2623
6. A.S. Weiss, J. Gralla, L. Chan, P. Klem, and A.C. Wiseman Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies Clin J Am Soc Nephrol 3 2008 1812 1819
7. E. Ramos, C.B. Drachenberg, R. Wali, and H.H. Hirsch The decade of polyomavirus BK-associated nephropathy: state of affairs Transplantation 87 2009 621 630
8. H.H. Hirsch, and J. Steiger Polyomavirus BK Lancet Infect Dis 3 2003 611 623
9. R.J. Knight, L.W. Gaber, S.J. Patel, J.M. DeVos, L.W. Moore, and A.O. Gaber Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis Transplantation 95 2013 949 954
10. B.H. Chung, Y.A. Hong, H.G. Kim, I.O. Sun, S.R. Choi, and H.S. Park Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy Transpl Int 25 2012 687 695
11. D.C. Brennan, I. Agha, D.L. Bohl, M.A. Schnitzler, K.L. Hardinger, and M. Lockwood Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction Am J Transplant 5 2005 582 594
12. F. Ginevri, A. Azzi, H.H. Hirsch, S. Basso, I. Fontana, and M. Cioni Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients Am J Transplant 7 2007 2727 2735
13. C. Alméras, V. Foulongne, V. Garrigue, I. Szwarc, F. Vetromile, and M. Segondy Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study Transplantation 85 2008 1099 1104
14. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 9 Suppl 3 2009 S1 155
15. H.H. Hirsch, and P. Randhawa AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation Am J Transplant 13 13 Suppl 4 2013 179 188
16. H.B. Viscount, A.J. Eid, M.J. Espy, M.D. Griffin, K.M. Thomsen, and W.S. Harmsen Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy Transplantation 84 2007 340 345
17. C. Costa, M. Bergallo, S. Astegiano, M.E. Terlizzi, F. Sidoti, and G.P. Segoloni Monitoring of BK virus replication in the first year following renal transplantation Nephrol Dial Transplant 23 2008 3333 3336
18. X.L. Pang, K. Doucette, B. LeBlanc, S.M. Cockfield, and J.K. Preiksaitis Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study J Clin Microbiol 45 2007 3568 3573
19. N. Elfadawy, S.M. Flechner, X. Liu, J. Schold, D. Tian, and T.R. Srinivas The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation Transpl Int 26 2013 822 832
20. H.H. Hirsch, F. Vincenti, S. Friman, M. Tuncer, F. Citterio, and A. Wiecek Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study Am J Transplant 13 2013 136 145
21. D. Pérez-Torres, J. Bertrán-Pasarell, E. Santiago-Delpín, M. González-Ramos, S. Medina-Mangual, and L. Morales-Otero Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population Transpl Infect Dis 12 2010 16 22
22. A. Hässig, M. Roos, A. Etter, W. Bossart, N. Müller, and M. Schiesser Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor Transpl Infect Dis 16 2014 44 54
23. C.H. Rinaldo, and H.H. Hirsch Antivirals for the treatment of polyomavirus BK replication Expert Rev Anti Infect Ther 5 2007 105 115
24. H.M. Wadei, A.D. Rule, M. Lewin, A.S. Mahale, H.A. Khamash, and T.R. Schwab Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN) Am J Transplant 6 2006 1025 1032
25. O. Johnston, D. Jaswal, J.S. Gill, S. Doucette, D.A. Fergusson, and G.A. Knoll Treatment of polyomavirus infection in kidney transplant recipients: a systematic review Transplantation 89 2010 1057 1070.